Guidelines and implementation | Inadequate guidelines for dispensing, education, and delivery |
Target groups for intervention are not defined (ie, who will be trained?) |
A better naloxone delivery system is required |
Medicolegal uncertainty | Medicolegal complexities for family physicians and deliverer not yet elucidated |
Potential for misuse of the intervention |
Support | Lack of support from other relevant providers; political resistance |
Lack of specific funding structure to compensate physicians |
Equity or stigma | Barriers for access among some groups (eg, those for whom there are language barriers, those who are homeless) |
Stigma for patients carrying naloxone |
Evidence | Lack of high-quality evidence of effectiveness in family practice |